Inclusion Criteria:  Children and adolescents aged three to 16 years of age. Atopic dermatitis, in accordance with the U.K Working Party's Diagnostic Criteria. Moderate severity on both Eczema Area and Severity Index (EASI) and Scoring Atopic Dermatitis (SCORAD) scores. (I.e. 7.1-21 EASI and 29-48.9 SCORAD) Not currently infected eczema. Able to give informed consent or have a parent/guardian able and willing to give informed consent.  Exclusion Criteria:  Known sensitivity or contact dermatitis to emollients, topical corticosteroids or any of its constituents. Currently infected eczema or frequent episodes of infected eczema requiring antibiotics. Currently on phototherapy, oral immunosuppressant, monoclonal antibodies for the treatment of eczema one month prior to start of study. Usage of any topical steroids or calcineurin inhibitors one week prior to start of study. Unable to give informed consent or have a parent/guarding unwilling to give consent.